These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34407725)

  • 1. Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses.
    Monaco A; Fraldi A
    Autophagy; 2021 Nov; 17(11):3875-3876. PubMed ID: 34407725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Mucopolysaccharidoses, an Update.
    Fecarotta S; Tarallo A; Damiano C; Minopoli N; Parenti G
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucopolysaccharidoses--biochemical mechanisms of diseases and therapeutic possibilities].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):133-47. PubMed ID: 21913414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases.
    Gaffke L; Pierzynowska K; Podlacha M; Brokowska J; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):498-506. PubMed ID: 31855304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has resveratrol a potential for mucopolysaccharidosis treatment?
    Rintz E; Pierzynowska K; Podlacha M; Węgrzyn G
    Eur J Pharmacol; 2020 Dec; 888():173534. PubMed ID: 32877657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets.
    Leal AF; Benincore-Flórez E; Rintz E; Herreño-Pachón AM; Celik B; Ago Y; Alméciga-Díaz CJ; Tomatsu S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model.
    D'Avanzo F; Zanetti A; Dardis A; Scarpa M; Volpi N; Gatto F; Tomanin R
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach.
    Pierzynowska K; Deresz P; Węgrzyn G; Gaffke L
    Metab Brain Dis; 2023 Aug; 38(6):2133-2144. PubMed ID: 37195412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
    Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
    Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know.
    Filocamo M; Tomanin R; Bertola F; Morrone A
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):129. PubMed ID: 30442161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.
    Rintz E; Gaffke L; Podlacha M; Brokowska J; Cyske Z; Węgrzyn G; Pierzynowska K
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis.
    Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Piotrowska E; Narajczyk M; Gabig-Cimińska M
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB.
    Scarcella M; Scerra G; Ciampa M; Caterino M; Costanzo M; Rinaldi L; Feliciello A; Anzilotti S; Fiorentino C; Renna M; Ruoppolo M; Pavone LM; D'Agostino M; De Pasquale V
    iScience; 2024 Mar; 27(3):108959. PubMed ID: 38361619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.